Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2003
08/14/2003US20030153749 Method for the production of caprolactam
08/14/2003US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153580 Cis-imidazolines
08/14/2003US20030153567 N-phenyl imidazole derivatives
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1334084A2 Phosgene-free process for preparing carbamates
08/13/2003EP1333828A2 Prevention of development of dyskinesias
08/13/2003EP1333795A1 Novel coupler for use in oxidative hair dyeing
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1178987B1 Substituted benzoylisoxazoles and the use thereof as herbicides
08/13/2003EP0979083B1 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
08/13/2003EP0850225B1 Intermediate for preparing a pharmaceutically active compound
08/13/2003CN1436171A Method for production of caprolactam
08/13/2003CN1117732C Noval Dihydronaphthalene compound and process for producing same
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605201 Charge transfer compounds comprising osmium compounds coupled to polymers, used as biosensors
08/12/2003US6605200 Polymeric transition metal complexes and uses thereof
08/12/2003US6605124 Naphthol hair dyes for keratinous fibers
08/07/2003WO2003064398A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
08/07/2003WO2003064396A1 Hydroxyalkanoyl aminopyrazoles and related compounds
08/07/2003WO2003063861A1 Fibrosis inhibitor
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063781A2 Substituted imidazoles as cannabinoid receptor modulators
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003US20030149273 Complexes of N-heterocyclic carbenes and the use thereof
08/07/2003US20030149208 Living free radical polymerization initiated by an alkoxyamine initiator or nitroxide
08/07/2003US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor
08/07/2003US20030149089 Antibacterial compounds
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003CA2474588A1 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
08/07/2003CA2474451A1 Cycloalkyl inhibitors of potassium channel function
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/06/2003EP1333321A1 Phenolic infrared couplers
08/06/2003EP1333028A1 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1189929B1 Factor viia inhibitors
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434039A Process for preparing 1,3-dibenzyl imidazoline-2-ketone-cis-4, 5-dicarboxylic acid (Ôàá)
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/05/2003US6603019 Phenylacetic or heteroarylacetic acid derivatives, retinoic acid inducible enzyme, used to treat diseases responsive to retinoids
08/05/2003US6603018 Rockets; propullants
08/05/2003US6603014 Use of cyclic enamines as light protection agents
08/05/2003US6602897 For example, 2-((2-bromo-3-chloro-5-dimethylamino-6-methylphenyl)imino)imid azolidine
08/05/2003US6602883 Inhibitors of farnesyl protein transferase
08/05/2003US6602877 Imidazolyl-cyclic acetals
08/05/2003US6602832 Oil-soluble additive compositions for lubricating oils
08/05/2003US6602831 Oil-soluble additives for lubricating oils
07/2003
07/31/2003WO2003062251A1 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
07/31/2003WO2003062249A2 Coordination complex
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062208A1 Onium salts with weakly coordinating imidazolidine anion as cationic initiators
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003WO2003062175A1 Method for producing alkenyl aromatic compounds
07/31/2003WO2003062171A2 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
07/31/2003WO2003061652A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/31/2003WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003WO2002030863A3 Ether compounds and compositions for cholesterol management and related uses
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai
07/31/2003US20030144335 Nitroimidazole compound for allergic conjunctivitis or allergic rhinitis
07/31/2003US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4
07/31/2003US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics
07/31/2003US20030144311 Propanoic acid derivatives as intergrin receptor antagonists
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/31/2003US20030144290 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
07/31/2003US20030144279 5-Heterocyclo-pyrazoles
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/31/2003US20030143235 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
07/31/2003US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
07/31/2003CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/30/2003EP1187817B1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/30/2003EP0910376B1 Use of clotrimazole and related compounds in the treatment of diarrhea
07/30/2003CN1433420A Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof
07/30/2003CN1433397A Method for the prepararation of enantiomerically enriched compounds
07/30/2003CN1433297A Topical compositions comprising protected functional thiols
07/30/2003CN1432570A Prepn process of alkyl imidazolidone methacrylate
07/30/2003CN1116287C Diphenyl heterocycles as potassium channel modulators
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/29/2003US6600035 6-(substituted methylene) penems and intermediates
07/29/2003US6599926 Anticoagulant agents for treatment and prevention of thromboembolic disorders
07/29/2003US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action
07/29/2003US6599910 Substituted triazole compounds
07/29/2003US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/29/2003US6599587 Silver, gold, copper, palladium, nickel or platinum complexed with one or two imidazolylidene compounds and optionally abetadiketone; photopatterning without a resist
07/29/2003CA2114136C Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them
1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 345